2021
DOI: 10.1016/j.bioorg.2021.105296
|View full text |Cite
|
Sign up to set email alerts
|

Novel inhibitors of eukaryotic elongation factor 2 kinase: In silico, synthesis and in vitro studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 55 publications
0
9
0
Order By: Relevance
“…However, its 3D structure prediction using alphafold (v.2) is available at the UniProt (AF-000418-F1-model_v2). When we superimpose our 3D model 17 with the alphafold model, both models aligned well to each other for the ligand binding domain (i.e. regions of residue numbers 107 to 326).…”
Section: Rsc Medicinal Chemistry Research Articlementioning
confidence: 79%
See 4 more Smart Citations
“…However, its 3D structure prediction using alphafold (v.2) is available at the UniProt (AF-000418-F1-model_v2). When we superimpose our 3D model 17 with the alphafold model, both models aligned well to each other for the ligand binding domain (i.e. regions of residue numbers 107 to 326).…”
Section: Rsc Medicinal Chemistry Research Articlementioning
confidence: 79%
“…2). 17,19 Thin layer chromatography (TLC) was used to observe the progress of the reaction. The reactions were performed with high yields.…”
Section: Chemistrymentioning
confidence: 99%
See 3 more Smart Citations